Overview

Pioglitazone on Pancreatic Steatosis and Bone Health

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Randomized, double blind, placebo controlled trial evaluating the effect of pioglitazone on pancreatic fat content and bone turnover markers.
Phase:
N/A
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Institutes of Health (NIH)
Treatments:
Pioglitazone